Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Oramed Pharmaceuticals Inc. Director's Dealing 2022

Apr 4, 2022

6965_dirs_2022-04-04_fb30890f-a2a1-4a55-9554-7ab6c8d1a602.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2022-04-01

Reporting Person: Rozov Yadin (Director)

More from Oramed Pharmaceuticals Inc.

Interim / Quarterly Report 2026
May 19
Director's Dealing 2026
Mar 18
Director's Dealing 2026
Mar 18
Director's Dealing 2026
Mar 18
Director's Dealing 2026
Mar 18
Regulatory Filings 2026
Feb 20
Major Shareholding Notification 2026
Feb 9
Director's Dealing 2026
Jan 29
Major Shareholding Notification 2026
Jan 29
Director's Dealing 2026
Jan 29
View all filings →